WHO ICTRP trial
Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of…
EUCTR2011-000536-28-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-000536-28-DE |
|---|---|
| Public title | Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of exudative age-related macular degeneration |
| Scientific title | Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of exudative age-related macular degeneration |
| Primary sponsor | Alcon Research Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United States;Austria;Australia;Israel;Germany |
| Conditions | wet age-related macular degeneration MedDRA version: 14.1 Level: PT Classification code 10064930 Term: Age-related macular degeneration System Organ Class: 10015919 - Eye disorders ;Therapeutic area: Diseases [C] - Eye Diseases [C11] |
| Interventions | Product Name: ESBA1008, 10 mg/ml Pharmaceutical Form: Solution for injection INN or Proposed INN: not yet assigned CAS Number: not assigned Current Sponsor code: ESBA1008 Other descriptive name: anti-VEGF scFv antibody fragment… |
| Registration date | Feb 9, 2011 |
| Target size | 194 |
| Secondary IDs | C-10-083 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: